台灣東洋藥品工業股份有限公司 2025 Sustainability Report

Report summary

• This page summarizes the 2025 sustainability report and ESG report PDF source for 台灣東洋藥品工業股份有限公司 (4105).
• The reporting period is 2025/01/01 to 2025/12/31, in the 生技醫療業 industry.
• third-party information includes verification body 法標國際認證股份有限公司; this can be used to review report verification, assurance, and disclosure standards.
• Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.

Report details

Company

台灣東洋藥品工業股份有限公司（4105）

Reporting Year

2025

Disclosure Period

2025/01/01 to 2025/12/31

Industry

生技醫療業

Third-party information

third-party information includes verification body 法標國際認證股份有限公司

PDF source

The original ESG report PDF can be downloaded or opened from this page

2025 ESG Metrics and Industry Comparison

Greenhouse Gas Emissions

Scope 1 Emissions (Tons CO2e)

2,059

Reporting Boundary：已完成母公司

Verification：是

Scope 2 Emissions (Tons CO2e)

7,671

Reporting Boundary：已完成母公司

Verification：是

Scope 3 Emissions (Tons CO2e)

2,711

Reporting Boundary：已完成母公司

Verification：是

Energy Management

Renewable Energy Share

Not disclosed

Reporting Boundary：Not disclosed

Verification：ISO 14064-3

Water Management

Water Use (Metric Tons)

137,616

Reporting Boundary：母公司盤查邊界包含「六堵廠」、「中壢廠」、「製劑研發中心」及「總公司」

Verification：Not disclosed

Board of Directors

Board Seats (Including Independent Directors)

9

Independent Director Seats

3

Female Director Ratio

22.2%

Ranked 44 among 96 companies in the same industry (percentile 47).

Board Meeting Attendance Rate

100%

Ranked 1 among 96 companies in the same industry (percentile 74).

Independent Director Ratio

33.3%

Ranked 71 among 96 companies in the same industry (percentile 7).

Source: Taiwan Stock Exchange / Taipei Exchange, Corporate ESG Disclosure Summary (2025), under the Open Government Data License, version 1.0. Open Government Data License, Version 1.0

How to use this report

• Compare how 台灣東洋藥品工業股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2025.
• Confirm the reporting period, third-party verification or assurance information, and downloadable ESG report PDF source.
• Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.